A Multicenter, Single-Arm Phase II Study of Pemetrexed Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer
| Autor: | Martin, Miguel, Blasinska-Morawiec, Maria, Salas, J. Fernando, Falcon, Silvia, Rolski, Janusz, Ferrari, Bruno L., Gulyas, Stephen, Liu, Yushan, Benhadji, Karim A. |
|---|---|
| Zdroj: | In Clinical Breast Cancer 2009 9(3):155-160 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect